Morgan Stanley slides today: Key reasons behind the decline

Traders Union
All News
Financial News
Morgan Stanley slips 2.10% today

Highlights

U.S. Justice Department documents confirm Morgan Stanley opened accounts for Jeffrey Epstein's trusts between 2015 and 2019, following his 2008 conviction.
This disclosure directly links Morgan Stanley to client activities involving Jeffrey Epstein after his registration as a sex offender.
Morgan Stanley shares trade at $172.88, below the MA-20 and MA-50, with dynamic support at MA-100 ($171.25) and resistance in the $179–$180 zone.

Epstein account disclosures shift sentiment amid regulatory scrutiny

Documents from the U.S. Justice Department confirm that Morgan Stanley opened accounts for Jeffrey Epstein's trusts between 2015 and 2019, after his 2008 conviction and sex offender registration. This disclosure directly links Morgan Stanley to client activities involving Epstein following his legal issues.

Anton Kharitonov, expert at Traders Union, notes that Morgan Stanley’s price action reflects persistent short-term selling with limited technical support nearby. He sees the stock trading below key moving averages, confirming a bearish setup. Regulatory developments involving the Epstein accounts introduce reputational risk that may further dampen sentiment. With trend strength weak and momentum indicators mixed, Kharitonov questions the sustainability of any near-term recovery. "Until MS reclaims and holds $179, sellers remain firmly in control and compliance risks cannot be overlooked."

Viktoras Karapetjanc, expert at Traders Union, views the current setup as a healthy consolidation within a strong long-term uptrend. He believes Morgan Stanley’s structure remains bullish over the medium term, despite recent pressure from negative news. Consolidation above MA-200 signals institutional confidence and potential for further growth. Karapetjanc highlights that the current volatility band offers strategic opportunities for positioning ahead of expected upside. "The bullish structure remains intact — I expect MS to resume its uptrend once short-term selling is absorbed."

Parshwa Turakhiya, analyst, sees a market caught in a tug-of-war between sellers and technical support. The sideways bias between $167 and $173 presents tactical swing trade opportunities for agile participants. Sentiment is unsettled after the news, but a break above $179 could quickly shift momentum. Turakhiya points to near-term levels as key for short-duration traders. "If $171 holds, I’m watching for a swift bounce toward resistance — uncertainty favors quick, opportunistic setups now."

Mixed momentum and weak trend as MS tests MA-100 support

Nearest dynamic support for MS is anchored at the MA-100 near $171.25, with resistance overhead defined by the $179 – $180 range, corresponding to the Ichimoku Kijun and MA-50. Momentum signals on the daily chart are mixed — MACD suggests weakened momentum with a bearish tilt, and ADX at 14.78 signals low trend strength. RSI at 47.40 and CCI are both drifting lower, signaling mild selling momentum, while intraday indicators such as Stoch RSI and BBP produce mixed overbought/oversold signals. The Awesome Oscillator confirms a bearish bias as the stock trades near today's range low ($173.10 – $176.00) after an initial gap down. Daily volatility remains moderate, with sellers prevailing since the open. Oscillator divergences reflect an uncertain short-term outlook consistent with the day's downward momentum.

Last time, analysts noted that Morgan Stanley shares are trading below short- and medium-term moving averages but remain well above long-term support, reflecting persistent seller pressure despite underlying strength. Technical indicators show mixed momentum and oversold signals, with resistance in the $178 area and key support near the MA-200, suggesting a cautious near-term outlook amid low volatility and divergent price signals.

Source of Data: MS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.